Targeting USP18 overcomes acquired resistance in hepatocellular carcinoma by regulating NCOA4 deISGylation and ferroptosis
Abstract Targeted therapy resistance has become a major challenge for hepatocellular carcinoma (HCC) treatment. Triggering ferroptosis emerges as a promising strategy to overcome therapeutic resistance. Here, we have identified ubiquitin-specific protease 18 (USP18), a member of the deubiquitinating...
Saved in:
| Main Authors: | Shengtao Ye, Junxin Chen, Ying Zheng, Mengmeng He, Yanqiu Zhang, Yang Cheng, Yingrong Leng, Enyi Wu, Lingyi Kong, Hao Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-06-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07772-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spermidine reduces ISGylation and enhances ISG15–USP18 interaction
by: Haruka Etori, et al.
Published: (2025-05-01) -
NCOA5 induces sorafenib resistance in hepatocellular carcinoma by inhibiting ferroptosis
by: Shuang Gao, et al.
Published: (2025-05-01) -
RBX1 mitigates ferroptosis by inhibiting NCOA4-mediated ferritinophagy and contributes to the attenuation of intervertebral disc degeneration
by: Lu-Ping Zhou, et al.
Published: (2025-05-01) -
NCOA6 knockdown enhances RSL3-induced ferroptosis in pancreatic cancer cells and increases the sensitivity to gemcitabine
by: Jia Yuming, et al.
Published: (2025-03-01) -
ISGylation and E3 ubiquitin ligases: an Atlantic salmon genetic perspective
by: Unni Grimholt, et al.
Published: (2025-06-01)